Recent Corporate Highlights
* Initiated a Phase 2 clinical trial for PYY(3-36) Nasal Spray for
* Initiated a Phase 2 clinical trial for Insulin Nasal Spray for diabetes
* Announced promotion of Henry "Rick" Costantino to Chief Scientific
Officer of Delivery
Conference Call and Webcast Information
Management will host a conference call to review our financial results for the period ended September 30, 2007 and recent business developments. The call is scheduled for today, October 29, 2007, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time). To participate in the live conference call, U.S. residents should dial (866) 831-6243 and international callers should dial (617) 213- 8855. The access code for the live conference call is 60453924. To access the 24-hour telephone replay, U.S. residents should dial (888) 286-8010 and international callers should dial (617) 801-6888. The access code for the replay is 53042322.
Alternatively, log on to http://www.nastech.com to access a live webcast or the subsequent archive. Please connect to the Investor section of Nastech's website several minutes prior to the start of the live conference call to ensure adequate time for any software download that may be necessary.
Nastech is a biopharmaceutical company developing innovative products
based on proprietary molecular biology-based drug delivery technologies.
Nastech and our collaboration partners are developing products for multiple
therapeutic areas including osteoporosis, obesity, diabetes, autism,
respiratory diseases and inflammatory conditions. Additional information
about Nastech is available at http://ww
|SOURCE Nastech Pharmaceutical Company Inc.|
Copyright©2007 PR Newswire.
All rights reserved